Kellie N. Smith
Impact in
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Oncology 24
- Cancer Immunotherapy and Biomarkers 20
- CAR-T cell therapy research 7
- Immunology 18
- Immunotherapy and Immune Responses 13
- Immune Cell Function and Interaction 9
- T-cell and B-cell Immunology 5
- Co-authors
- Drew M. Pardoll (14 shared papers)Patrick M. Forde (13 shared papers)Suzanne L. Topalian (8 shared papers)Mark Yarchoan (1 shared paper)Leisha A. Emens (1 shared paper)Valsamo Anagnostou (15 shared papers)Jiajia Zhang (11 shared papers)Franck Housseau (3 shared papers)
- Journals
- Journal of Clinical Oncology (8 papers)Frontiers in Immunology (3 papers)Cell Reports Medicine (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Annals of Oncology (2 papers)
- Partner nations
- United StatesMalaysiaBelgium
In The Last Decade
Kellie N. Smith
40 papers receiving 810 citations
Kellie N. Smith's Hit Papers
Peers
Comparison fields: 5 of 70
- Immunology 328
- Oncology 375
- Virology 65
- Pulmonary and Respiratory Medicine 135
- Infectious Diseases 76
Countries citing papers authored by Kellie N. Smith
This map shows the geographic impact of Kellie N. Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kellie N. Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kellie N. Smith more than expected).
Fields of papers citing papers by Kellie N. Smith
This network shows the impact of papers produced by Kellie N. Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kellie N. Smith. The network helps show where Kellie N. Smith may publish in the future.
Co-authors
The 25 scholars most cited alongside Kellie N. Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 43 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy Hit paper breakdown → | 2023 | 174 |
| 2 | 2018 | 105 | |
| 3 | 2016 | 104 | |
| 4 | 2023 | 51 | |
| 5 | 2023 | 44 | |
| 6 | 2019 | 30 | |
| 7 | 2013 | 28 | |
| 8 | 2019 | 22 | |
| 9 | 2017 | 22 | |
| 10 | 2025 | 21 | |
| 11 | 2022 | 19 | |
| 12 | 2022 | 18 | |
| 13 | 2016 | 17 | |
| 14 | 2024 | 16 | |
| 15 | 2016 | 15 | |
| 16 | 2020 | 15 | |
| 17 | 2014 | 14 | |
| 18 | 2021 | 12 | |
| 19 | 2025 | 11 | |
| 20 | 2013 | 9 |
About Kellie N. Smith
Kellie N. Smith is a scholar working on Oncology, Immunology, Virology, Surgery and Molecular Biology, having authored 43 papers that have together received 816 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (20 papers), Immunotherapy and Immune Responses (13 papers), Immune Cell Function and Interaction (9 papers), HIV Research and Treatment (9 papers), CAR-T cell therapy research (7 papers), T-cell and B-cell Immunology (5 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Esophageal Cancer Research and Treatment (4 papers). The work is most often cited by research in Immunology (328 citations), Oncology (375 citations), Virology (65 citations), Pulmonary and Respiratory Medicine (135 citations) and Infectious Diseases (76 citations). Kellie N. Smith has collaborated with scholars based in United States, Malaysia and Belgium. Frequent co-authors include Drew M. Pardoll, Patrick M. Forde, Suzanne L. Topalian, Mark Yarchoan, Leisha A. Emens, Valsamo Anagnostou, Jiajia Zhang, Franck Housseau, Julie R. Brahmer and Ada Tam. Their work appears in journals such as Journal of Clinical Oncology, Frontiers in Immunology, Cell Reports Medicine, Journal for ImmunoTherapy of Cancer and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.